ZFIN ID: ZDB-FISH-160519-4
Fish name: socs1aihb33/ihb33(AB)
Genotype: socs1aihb33/ihb33 (AB)
Targeting Reagent: none
HUMAN DISEASE MODELED by socs1aihb33/ihb33(AB)
Human Disease Conditions Citations
fatty liver disease standard conditions Dai et al., 2015
GENE EXPRESSION
Gene expression in socs1aihb33/ihb33(AB)
Reporter gene expression No data available
PHENOTYPE
Phenotype in socs1aihb33/ihb33(AB)
Phenotype Conditions Figures
blood glucose homeostasis process quality, normal standard conditions Fig. 5 from Dai et al., 2015
blood plasma ins expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
blood plasma response to insulin decreased process quality, abnormal standard conditions Fig. 5 from Dai et al., 2015
female organism has extra parts of type liver lipid droplet, abnormal standard conditions text only from Dai et al., 2015
lateral plate mesoderm gata1a expression increased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
liver ab5-akt labeling decreased amount, abnormal control Fig. 5 from Dai et al., 2015
liver hkdc1 expression decreased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver gck expression decreased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver scd expression decreased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver pck1 expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver ldlra expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver ins expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver insrb expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver ab3-stat5 labeling increased amount, abnormal standard conditions Fig. 6 from Dai et al., 2015
liver hif1al expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver apoa4a expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver foxo1a expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver g6pc1a.1 expression increased amount, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver ab11-akt labeling increased amount, abnormal control Fig. 5 from Dai et al., 2015
liver cellular response to glucagon stimulus decreased process quality, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver cellular response to insulin stimulus decreased process quality, abnormal standard conditions Fig. 5 from Dai et al., 2015
liver lipid droplet increased amount, abnormal standard conditions Fig. 4Fig. 5 from Dai et al., 2015
liver regulation of tyrosine phosphorylation of STAT protein disrupted, abnormal standard conditions Fig. 6 from Dai et al., 2015
male organism has extra parts of type liver lipid droplet, abnormal standard conditions text only from Dai et al., 2015
nucleate erythrocyte increased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
protein phosphorylation disrupted, abnormal standard conditions Fig. 5 from Dai et al., 2015
regulation of protein kinase B signaling disrupted, abnormal standard conditions Fig. 5 from Dai et al., 2015
subcutaneous fat decreased amount, abnormal standard conditions Fig. 4 from Dai et al., 2015
whole organism ab3-stat5 labeling amount, ameliorated chemical treatment: tyrphostin B42 Fig. 2 from Dai et al., 2015
whole organism ab1-hbbe1 labeling amount, ameliorated chemical treatment: tyrphostin B42 Fig. 2 from Dai et al., 2015
whole organism il1b expression decreased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism tnfa expression decreased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism il6 expression decreased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism decreased size, abnormal standard conditions Fig. 3 from Dai et al., 2015
whole organism decreased weight, abnormal standard conditions Fig. 3 from Dai et al., 2015
whole organism ab1-hbbe1 labeling increased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism ifng1 expression increased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism ab3-stat5 labeling increased amount, abnormal standard conditions Fig. 2 from Dai et al., 2015
whole organism morbidity, abnormal standard conditions Fig. 3 from Dai et al., 2015
whole organism size, normal standard conditions Fig. 3 from Dai et al., 2015
whole organism growth decreased rate, abnormal standard conditions Fig. 3 from Dai et al., 2015
whole organism growth rate, normal standard conditions Fig. 3 from Dai et al., 2015

CITATIONS  (1)